PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's
manufacturing facility in Arnprior, Canada, which the drug giant
has been trying to pass on for over a year.
Patheon has finally revealed its plans to tackle the ongoing
problems it has been facing with its Puerto Rican operations, which
are draining the firm of profitability.
GE Healthcare and Novavax have a vision - a state-of-the-art
pandemic influenza vaccine manufacturing facility solution with the
ability to produce vaccines quickly, which can be marketed as a
product to international countries.
Separations expert Millipore is collaborating with Rohm and Haas
Company to develop new high-performance chromatography products for
use in biopharmaceutical manufacturing.
Bristol-Myers Squibb (BMS) has finally detailed its plans to trim
the fat and save cash, months after first revealing that big
changes would be on the cards.
Abbott is to shut its doors on its Galway, Ireland, facility -
taking 500 jobs with it - as the market moves into murky waters
over the future of vascular stents.
Pharmaceutical Profiles, H.D. Smith, Consort Medical, Questcor
Pharmaceuticals, and Sunesis Pharmaceuticals have all had people on
the move in the world of pharmaceutical manufacturing.
Medgenics' Biopump could be the solution to the issues surrounding
protein therapy and is set to take on the $51bn US
biopharmaceutical market after raising £3.28m ($6.76m) in funding
in its Initial Public Offering.
Spanish firm Almirall is working on a new chronic obstructive
pulmonary disease (COPD) treatment combined with a hi-tech easy use
inhaler, creating what it hopes will be another competitive product
from its in-house pipeline.
Merck has settled on a site in south east Ireland for a new
vaccines and biologics facility, investing €200m ($280m) in its
third facility on the island.
Specialty pharmaceutical company Akorn has signed up with
India-based Cipla in an exclusive manufacturing and supply
agreement for an undisclosed inhaled drug.
The official report into good manufacturing practice (GMP) failures
that caused dangerous contamination and a Europe-wide recall of
Roche's HIV drug Viracept (nelfinavir) claims the firm simply did
not understand its own manufacturing...
After a clinical hiccough five months ago set Coley
Pharmaceutical's drug development funding back several years,
Pfizer has stepped in to save the day, snapping up the biotech for
$164m.
AstraZeneca's axe has made its latest appearance in South Africa,
with the sale of a packaging plant and the formation of an
outsourcing deal with its new owners.
Despite Genentech's recent decision to push out the cut-off date to
ban the sale of cancer drug Avastin (bevacizumab) to compounding
pharmacies in the US to restrict off-label use, ophthalmologists
still find the firm's...
Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
Indian generics specialist Wockhardt is continuing its drive to
strengthen its foothold in the US market, snapping up US firm
Morton Grove Pharmaceuticals.
As the fires in California continue to rage, Pfizer and other
pharma and biotech companies all over Southern California are
bracing themselves for closures and even evacuations of their
facilities.
A US start-up firm is gearing up to launch an online database where
researchers can access a variety of drug discovery service
providers across the globe.
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Avecia Biologics has signed a development and manufacturing deal
with US firm BaroFold, making use of the company's protein
processing technology to produce its lead interferon-based multiple
sclerosis (MS) candidate.
Denmark-based Bavarian Nordic has received an advance payment of
$50m (€35.4m) from the US Government for meeting milestones in one
of its smallpox vaccine supply contracts.
UK-based TeraView has had its tablet imaging technology backed by
the US Food and Drug Administration (FDA), following a study by the
regulatory agency.
Denmark's Novo Nordisk, could be on the verge of selling off its
engineering division, if reports in the local business daily Borsen
are to be believed.
Amgen has announced the 'indefinite postponement' on plans for its
$1bn (€0.71bn) manufacturing facility in Cork, Ireland, following
further navel gazing by the company.
Pharmaceutical companies not only have to face the consequences of
a burgeoning counterfeit drug black market but have to contend with
the theft of their own manufactured drugs for illicit uses,
according to a US consumer advocacy...
Novartis has hooked up with the Massachusetts Institute of
Technology (MIT) to fund a project aimed at 'revolutionising'
pharmaceutical manufacturing and doing away with traditional
batch-based production techniques.
Dutch firm Crucell is hastily trying to reassure investors that its
popular cell line technology, PER.C6, was not to blame for the
failure of Merck's hotly touted HIV vaccine last week.
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...
Bispecific antibodies (BisAbs), which can bind to two distinct antigens, are prone to high levels of aggregate (10-30%), challenging traditional platform...
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
